Right-Wing Ad Equates Obamacare and Rape

A creepy new ad suggests if you sign up for Obamacare, you’ll be raped by a scary Uncle Sam clown.

National Journal
Lucia Graves
Sept. 19, 2013, 7:55 a.m.

Just in case Re­pub­lic­an ef­forts to re­peal Pres­id­ent Obama’s health care law fail (and they al­most cer­tainly will), con­ser­vat­ives have a fall­back plan …

Gen­er­a­tion Op­por­tun­ity, a co­ali­tion of right-lean­ing groups with ties to the Koch broth­ers, has re­leased a cam­paign video es­sen­tially telling col­lege stu­dents that if they sign up for Obama­care, a man in a creepy Uncle Sam cos­tume will jam a spec­u­lum down their va­gina!

The ad is some­what re­min­is­cent of this Bur­ger King com­mer­cial that in­volved a guy wak­ing up with a scary clown king in his bed, but the polit­ic­al mes­sage is less ab­stract. In this case, the mes­sage is that the gov­ern­ment is try­ing to for­cibly rape wo­men with a blunt met­al in­stru­ment. For your con­sid­er­a­tion:

There’s also a video aimed at col­lege men in which the creepy Uncle Sam clown ma­ter­i­al­izes out from un­der some near-child’s ex­am chair to pre­sum­ably fondle his pro­state. Be­cause that is what doc­tors do, right?

The videos, as Ya­hoo’s Chris Moody tell us, are part of a much lar­ger ef­fort to per­suade col­lege kids not to sign up for the health cov­er­age man­dated by Pres­id­ent Obama’s new law, the en­roll­ment peri­od for which be­gins Oct. 1. The law re­lies heav­ily on the in­volve­ment of the young and healthy, who sub­sid­ize the old and sick.

Gen­er­a­tion Op­por­tun­ity will tour 20 col­lege cam­puses later this month to spread this mes­sage, do­ing all the “cool kid” col­lege activ­it­ies, such as play­ing Cornhole and at­tend­ing col­lege-foot­ball tail­gate parties, and passing out beer koozies that read “opt out.” It’ll be set­ting up stands along­side pro-Obama­care groups like En­roll Amer­ica, passing out pizza and “lit­er­at­ure,” and try­ing to get kids to sign a pledge prom­ising not to sign up for in­sur­ance un­der the new law.

Be­cause noth­ing says cool like not hav­ing health care cov­er­age, and maybe, if these ads suc­ceed in scar­ing wo­men out of the an­nu­al Pap ex­ams they need, a dia­gnos­is of cer­vical can­cer.

MOST READ
What We're Following See More »
BUT HE’S NOT ADVOCATING FOR IT
Grassley Open to Lame Duck Hearings on Garland
14 hours ago
THE LATEST

Senate Judiciary Committee Chairman Chuck Grassley (R-IA) said Monday he'd now be willing to hold a hearing on Supreme Court nominee Merrick Garland in a lame-duck session of Congress. While he said he wouldn't push for it, he said if "Hillary Clinton wins the White House, and a majority of senators convinced him to do so," he would soften his previous opposition.

Source:
DOWN FROM POST-CONVENTION NUMBERS
Monmouth Has Clinton Up Seven
18 hours ago
THE LATEST

In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.

Source:
DEBATE PREP
Clinton Advisers Talking to Psychologists, Trump Ghostwriter
19 hours ago
THE LATEST

“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”

EPI-PEN PRICES
House Committee Investigating Mylan
21 hours ago
THE LATEST

The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.

Source:
×